GDF6 and rheumatoid arthritis: To this end, we further examined the specificity of SGm1 and SGm2 for RF/ACPA-negative RA patients by analyzing patients of another RF/ACPA-negative inflammatory disorder, ankylosing spondylitis (AS, n = 34), as well as a degenerative joint disease osteoarthritis (OA, n = 26).